Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer
Nemunaitis, J., Khuri, F., Ganly, I., Arseneau, J., Posner, M., Vokes, E., Kuhn, J., McCarty, T., Landers, S., Blackburn, A., Romel, L., Randlev, B., Kaye, S., Kirn, D.Volume:
19
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2001.19.2.289
Date:
January, 2001
File:
PDF, 78 KB
2001